Both in Pharmaceuticals
Jazz Pharmaceuticals vs Insmed
Over the past year JAZZ returned +66.0% and INSM returned −43.9%; their daily moves had a correlation of 0.12.
JAZZ +66.0% INSM −43.9%Growth of $1, one year, split-adjusted
| Metric | JAZZ | INSM |
|---|---|---|
| Price | $229.74 | $104.44 |
| Market cap | $14.91B | $22.91B |
| Today | +7.13% | −4.46% |
| 1 month | −2.7% | +0.6% |
| 6 months | +8.2% | −25.1% |
| Year to date | +35.1% | −40.0% |
| 1 year | +66.9% | −44.9% |
| Revenue growth (YoY) | +10.4% | +268.4% |
| Gross margin | 91.1% | 85.1% |
| Net margin | −38.9% | −19.1% |
| P/E (TTM) | 72.4× | — |
| Price / sales | 3.2× | 15.1× |
| Net cash | -$2.71B | $569.9M |
| Dividend yield | — | — |
| Volatility (60d) | 31.5% | 47.3% |
| Short % of float | 9.4% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).